Professor Paul Morgan
Prosiectau fel Prif Ymchwiliwr
- Targeting the terminal pathway in complement-driven disease (01.10.2016 - 30.09.2018)
- Target validation, indication selection/prioritisation, review of pre-clinical validation efforts and overall strategy (08.08.2016 - 18.09.2019)
- Testing activity of mAb CP010 (26.10.2018 - 25.10.2019)
- Testing novel agents in myasthenia gravis models (01.06.2019 - 31.12.2020)
- Testing novel agents in myasthenia gravis models (25.05.2015 - 31.03.2017)
Prosiectau fel Cyd-Ymchwiliwr
- A tooth for an eye? The role of innate immune activation in glaucoma (01.10.2017 - 31.03.2021)
- Automated 384-capacity real-time quantitative polymerase chain reaction (qPCR) facility (01.08.2012 - 31.07.2013)
- Brain Repair and Intracranial Neurotherapeutics - the Wales BRAIN Unit (01.04.2015 - 31.03.2018)
- CD59 as a Modulator of T Cell Activity In Vivo (01.06.2006 - 30.09.2008)
- Collaborative and redundant roles of CLRs in anti-fungal immunity (01.04.2013 - 31.03.2019)